Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 49.99%
March 31, 2026 -15.81K%
December 31, 2025 20.02%
September 30, 2025 -12.32K%
June 30, 2025 -1.05K%
March 31, 2025 -2.08K%
December 31, 2024 -184.2%
September 30, 2024 -360.5%
June 30, 2024 -17.24K%
March 31, 2024 -2.93K%
December 31, 2023
September 30, 2023 -868.1%
June 30, 2023 -835.6%
March 31, 2023 -910.7%
September 30, 2022 -774.2%
Date Value
June 30, 2022 -315.8%
March 31, 2022 -551.1%
December 31, 2021 -47.10%
September 30, 2021 -373.5%
June 30, 2021 -392.6%
March 31, 2021 -514.0%
December 31, 2020 -276.2%
September 30, 2020 -126.3%
June 30, 2020 -1.03K%
March 31, 2020 -372.5%
December 31, 2019 -78.95%
September 30, 2019 -292.0%
June 30, 2019 -1.05K%
March 31, 2019 -2.29K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Xencor, Inc. -42.42%
UroGen Pharma Ltd. -19.81%
Ironwood Pharmaceuticals, Inc. 45.37%
Viking Therapeutics, Inc. --
IDEAYA Biosciences, Inc. -1.27K%